Eli Lilly Q3 Revenue Jumps 39% as Mounjaro and Zepbound Sales Lift 2026 Forecast
The Eli Lilly Q3 2026 results show revenue up 39% to $24.4 billion and a higher revenue outlook, but lower EPS guidance after acquisition charges.
The Eli Lilly Q3 2026 results show revenue up 39% to $24.4 billion and a higher revenue outlook, but lower EPS guidance after acquisition charges.